Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • Biotech Trial of the Century Could Determine Who Owns CRISPR

    MIT Technology Review | Attorneys in a dispute over CRISPR gene-editing make their case to patent judges.

    Dec 7, 2016
  • Biotech Has A Solution For The Clean Water Crisis

    Forbes | As peak oil fears fade, water has emerged as the next resource crisis. The solution comes from drug development biotechnologies honed by the pharmaceutical industry.

    Dec 7, 2016
  • CRISPR Hearing Puts University of California on the Defensive

    STAT | The University of California has a steep hill to climb if it wants to overturn the 2014 decision awarding key CRISPR patents to the Broad Institute.

    Dec 7, 2016
  • AWS Wants To Dominate Beyond The Public Cloud With Lambda Updates

    Computerworld | Two years ago, Amazon Web Services made a splash when it introduced Lambda. Now, the company has gone even further to bring that technology outside of its core data center regions.

    Dec 6, 2016
  • At Late-Night ASH Talk Juno Execs Look Beyond Stalled Rocket Trial

    Xconomy | Juno Therapeutics is still mulling next steps for its lead product, an experimental cancer immunotherapy now stuck in limbo because five of 68 adult leukemia patients in its current study have died from severe brain swelling caused by the treatment.

    Dec 6, 2016
  • Groundbreaking Big Data Platform Can Improve The Quality Of Cancer Care

    Bio-IT World Contributed Commentary | CancerLinQ helps to gain insights from the 97% of cancer patients not involved in clinical trials to help deliver better, more data-driven decision-making.  

    Dec 5, 2016
  • Eurofins Genomics Creates Streamlined DNA Synthesizer

    Louisville Business First | Eurofins Genomics recently moved its headquarters to Louisville. Here's what they've been up to since.

    Dec 2, 2016
  • TGen Joins City of Hope System

    Bio-IT World News Brief  Translational Genomics Research Institute—TGen—has formed an alliance with City of Hope, a world-renowned independent research and cancer and diabetes treatment center, to make precision medicine a reality for patients. City of Hope hopes to provide a significant clinical setting to advance scientific discoveries made by TGen.

    Dec 2, 2016
  • Why Scientists Are Sequencing Newborns Genomes

    Forbes | Diagnosing hereditary disorders by sequencing the genomes of newborn babies.

    Dec 2, 2016
  • «
  • 361 (current)
  • 362
  • 363
  • 364
  • 365
  • 366
  • 367
  • 368
  • 369
  • 370
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy